On a conference call, executives claimed that a closely watched breast cancer pill and portfolio of weight loss medicines could bank more than $9 billion annually.
Johnson & Johnson failed to prove that the launch of a biosimilar version to its psoriasis drug Stelara will harm the company ...
Amneal Pharmaceuticals (NASDAQ:AMRX) outlined plans to acquire Kashiv BioSciences and reported preliminary first-quarter results during an investor call, with executives describing the deal as a strat ...
Add Yahoo as a preferred source to see more of our stories on Google. The FDA has introduced a new draft guidance The US Food and Drug Administration (FDA) has debuted new draft guidance that aims to ...
Owen Hosseinzadeh, Maarika Kimbrell, Christina Macdougall, Ph.d. FDA recently issued a new draft guidance titled Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. As of today, July 1st, Cyltezo (adalimumab-adbm) is commercially ...
The Company will also host a webcast with a live Q&A on Thursday, May 7, 2026, at 08:00 ET (12:00 GMT, 13:00 BST, 14:00 CEST). Slides and other material will be made available on ...
Patent expirations are increasingly concentrated in specialty, with >$43B in 2026 brand sales exposed and meaningful ...
As discussed previously (“New FDA Guidance Allows Biosimilar Applicants to Use Data From Outside the U.S. To Accelerate Their Approval in the ...
Acquisition Positions Amneal to Capitalize on $300B+ Global Biologics LOE Opportunity –– Transaction Accelerates Growth Profile and ...
Alongside the approval of Ponlimsi, the FDA is reviewing a BLA for TEV-45779, a biosimilar candidate for Xolair, covering all currently approved indications.
Within ten years, a patient may find that even a decades-old biologic treatment option they need has no other lower-cost alternative — and the one that’s available is prohibitively expensive and not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results